Silvia Caballero-Fenix

Cadiz, AN 11510, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Systematic review and adjusted indirect comparison of first-line immune checkpoint inhibitors in metastatic colorectal cancer.

Systematic review and adjusted indirect comparison of first-line immune checkpoint inhibitors in metastatic colorectal cancer.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: December 09, 2025

Economic Evaluation of Treatment With Trastuzumab Deruxtecan for HER2-Low Advanced or Metastatic Breast Cancer in Previously Treated Patients.

Economic Evaluation of Treatment With Trastuzumab Deruxtecan for HER2-Low Advanced or Metastatic Breast Cancer in Previously Treated Patients.

Journal: PharmacoEconomics - open
Published: June 15, 2025

Cost-Effectiveness of Sacituzumab Govitecan and Physician's Choice of Treatment in Patients with Metastatic Triple Negative Breast Cancer in Spain.

Cost-Effectiveness of Sacituzumab Govitecan and Physician's Choice of Treatment in Patients with Metastatic Triple Negative Breast Cancer in Spain.

Journal: Clinical drug investigation
Published: April 07, 2025

[Translated article] Caplacizumab in acute thrombotic thrombocytopenic purpura refractory to standard treatment.

[Translated article] Caplacizumab in acute thrombotic thrombocytopenic purpura refractory to standard treatment.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: November 14, 2024

[Translated article] The relevance of therapeutic positioning in the post-approval evaluation of new drugs.

[Translated article] The relevance of therapeutic positioning in the post-approval evaluation of new drugs.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: February 15, 2024

Switching of anti-migraine antibodies: effectiveness or regression to the mean?

Switching of anti-migraine antibodies: effectiveness or regression to the mean?

Journal: European journal of hospital pharmacy : science and practice
Published: February 13, 2024

Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system.

Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: August 18, 2023

Abemaciclib as adjuvant treatment for high-risk early breast cancer.

Abemaciclib as adjuvant treatment for high-risk early breast cancer.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: May 31, 2023

[Translated article] Adjusted indirect comparison of zanubrutinib and ibrutinib in first-line treatment of chronic lymphocytic leukemia.

[Translated article] Adjusted indirect comparison of zanubrutinib and ibrutinib in first-line treatment of chronic lymphocytic leukemia.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: January 24, 2023

Economic evaluation of adjuvant therapy with osimertinib in patients with early-stage non-small cell lung cancer and mutated EGFR.

Economic evaluation of adjuvant therapy with osimertinib in patients with early-stage non-small cell lung cancer and mutated EGFR.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 10, 2023

Systematic review and meta-analysis of interleulin-6 inhibitors in reducing mortality for hospitalized patients with COVID-19.

Systematic review and meta-analysis of interleulin-6 inhibitors in reducing mortality for hospitalized patients with COVID-19.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: October 02, 2022

Daratumumab-based therapies in transplant-ineligible patients with untreated multiple myeloma and hepatic dysfunction: A systematic review of subgroup analyses.

Daratumumab-based therapies in transplant-ineligible patients with untreated multiple myeloma and hepatic dysfunction: A systematic review of subgroup analyses.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: November 30, 2021
Showing 1-12 of 25

Last Updated: 09/26/2026